BSX stock: buy or sell?

BSX stock price: $38.47 0.79% At close on October 18th, 2019

Updated on:
October 18th, 2019


Boston Scientific shares grew 0.79% to $38.47 on October 18th.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide.

Should I buy BSX stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. That's why is so important to choose your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

Currently, Boston Scientific stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This is not a selling recommendation at all, just it's not the best moment to buy if you follow any of these trading strategies.

Is Boston Scientific stock a buy?

Banks and financial institutions publish stock ratings everyday. At, we detected 14 ratings published for BSX stock in the last month.

The general sentiment of these ratings is bullish for BSX stock, with 11 positive ratings.
Is BSX a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-9-5JPMorgan Chase & Co.n/aOverweight
2019-7-25Raymond Jamesn/aStrong-Buy
2019-6-27Stifel NicolausBuyIn-Line
2019-6-27Piper Jaffray Companiesn/aOverweight
2019-6-27Jefferies Financial GroupBuyPositive
2019-6-27Canaccord Genuityn/aBuy
2019-6-18Wells Fargo & Con/aOutperform
2019-2-8SunTrust Banksn/aBuy
2019-2-6Needham & Company LLCn/aBuy
2019-2-11Canaccord Genuityn/aBuy
2019-1-8Needham & Company LLCn/aBuy

BSX stock analysis

Daily outlook

Shares of Boston Scientific grew a tiny 0.79% and closed at $38.47.

Boston Scientific shares grew 0.79% to $38.47 on Oct/18. Since price and SMA200d lines crossed down on Oct/8, BSX fell $-1.88 per share (-4.66%).

BSX stock chart (daily)

Weekly outlook

After sliding a hair-raising -6.02% in a week last week, Boston Scientific closed this week at $38.47 and stepped up a slightly fine 0.63%.

Since last week, when BSX stock price broke down the 40-weeks moving avarage line, it slid $-2.06 per share (-5.08%). Trading stocks that are under the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.

BSX stock chart (weekly)

BSX stock price history

BSX stock went public on May 19th, 1992 with a price of $4.251. Since then, BSX stock grew a 805.20%, with a yearly average of 29.80%. If you had invested $1,000 in BSX stock in 1992, it would worth $8,052.00 today.

1: Adjusted price after possible price splits or reverse-splits.

BSX stock historical price chart

BSX stock reached 52-week highs on September/6 at $43.84, and all-time highs 2004-04-06 with a price of 46.1.

BSX stock price target is $46.50

Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last 30 days we found 13 price predictions for BSX stock:
BSX stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-25Raymond JamesRaises Target$48.00$50.004.2%
2019-6-27Stifel NicolausReiterates$44.00$46.004.5%
2019-6-27Piper Jaffray CompaniesRaises Target$42.00$50.0019%
2019-6-27Jefferies Financial GroupRaises Target$44.00$48.009.1%
2019-6-27Canaccord GenuityReiterates$43.00$46.007%
2019-6-18Wells Fargo & CoRaises Target$42.00$45.007.1%
2019-2-8SunTrust BanksReiteratesn/a$47.00-
2019-2-6Needham & Company LLCReiteratesn/a$43.00-
2019-2-13ArgusRaises Target$43.00$45.004.7%
2019-2-11Canaccord GenuityReiteratesn/a$45.00-
2019-1-8Needham & Company LLCReiteratesn/a$43.00-
(in average)$43.70$46.506.0%
The price prediction for Boston Scientific stock is $46.50, moving in a range between $50.00 and $43.00. In average, analysts' outlook on BSX price target is positive, upgrading the forecast by a 6.00% from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

On February, Boston Scientific presented its financial report, posting a slightly good growth for the Earnings per Share (EPS) ratio. Experts expected $0.37 per share, but Boston Scientific posted $0.39.
BSX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

In 2018, Boston Scientific annual revenues escalated a great 8.57% to $9,823.00 M dollars from $9,048.00 marked in 2017. In line, its income margin (compared to sales) boosted to 17.01%, that is $1,671.00 million.

BSX annual Sales and Income evolution
2013$7,140 M-$-121.00 M-1.7%-
2014$7,380 M3.36%$-119.00 M-1.6%-1.65%
2015$7,477 M1.31%$-239.00 M-3.2%100.84%
2016$8,386 M12.16%$347 M4.1%-245.19%
2017$9,048 M7.89%$104 M1.1%-70.03%
2018$9,823 M8.57%$1,671 M17.0%1,506.73%

Quarterly financial results

Boston Scientific posted $2,561.00 million in sales for 2018-Q4, a 7.02% up compared to previous quarter. Reported quarter income marked $386.00 million with a profit margin of 15.07%. Profit margin slightly fell a -2.98% compared to previous quarter when profit margin was 18.05%. When comparing revenues to same quarter last year, Boston Scientific sales marked a shining increase and rose a 6.35%.
BSX quarterly Sales and Income evolution
2017-Q2$2,260 M-$146 M6.5%-
2017-Q3$2,220 M-1.77%$283 M12.7%93.84%
2017-Q4$2,408 M8.47%$-615 M-25.5%-317.31%
2018-Q1$2,379 M-1.20%$298 M12.5%-148.46%
2018-Q2$2,490 M4.67%$555 M22.3%86.24%
2018-Q3$2,393 M-3.90%$432 M18.1%-22.16%
2018-Q4$2,561 M7.02%$386 M15.1%-10.65%
2019-Q1$2,493 M-2.66%$424 M17.0%9.84%

Boston Scientific ownership

When you are planning to invest in shares of a company, it's worth to check its ownership structure.

Boston Scientific shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 0.25% of all shares.

Bearish positions for BSX stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Boston Scientific:

Market cap$53.5 B$550.4 M$2.8 B$47.3 B$144.9 B
Total shares1,390.0 M37.6 M28.3 M208.0 M1,340.0 M
Float shares1,390.0 M37.1 M27.6 M206.5 M1,340.0 M
  - Institutional holdings (%)93.4%102.5%97.5%0.0%84.2%
  - Insider holdings (%)0.2%2.5%1.8%3.9%0.1%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

BSX summary

Friday, October 18th, 2019
Day range$38.01 - $38.66
Previous close$38.17
Session gain0.79%
Average true range$0.97
50d mov avg$41.31
100d mov avg$41.53
200d mov avg$39.71
Daily pattern
Weekly pattern

Boston Scientific performance

Performance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Boston Scientific to AngioDynamics, CONMED, Edwards Lifesciences, Medtronic, Merit Medical Systems, Stryker and Teleflex:
BSXBoston Scientific-8.95%9.57%5.28%
EWEdwards Lifescien...17.05%28.32%56.42%
MMSIMerit Medical Sys...-44.31%-46.86%-51.15%

Boston Scientific competitors

We picked a few stocks to conform a list of Boston Scientific competitors to examine if you are interested in investing in BSX:

Latest BSX stock news